IRIS
PATTAROZZI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.204
AS - Asia 35
SA - Sud America 11
NA - Nord America 1
Totale 6.251
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.204
CN - Cina 24
BR - Brasile 10
VN - Vietnam 4
SG - Singapore 3
BD - Bangladesh 1
BN - Brunei Darussalam 1
EC - Ecuador 1
IL - Israele 1
IQ - Iraq 1
MX - Messico 1
Totale 6.251
Salva come PNG Salva come JPEG
Città #
Genova 3.483
Genoa 1.817
Vado Ligure 461
Rapallo 434
Beijing 11
Bordighera 9
Ho Chi Minh City 2
Baghdad 1
Bandar Seri Begawan 1
Be'er Ya'aqov 1
Bom Despacho 1
Camboriú 1
Casimiro de Abreu 1
Cidade Ocidental 1
Guayaquil 1
Hanoi 1
Hải Dương 1
Mexico City 1
Monte Alegre de Sergipe 1
Nova Iguaçu 1
Nova Xavantina 1
Ribeirão Preto 1
Rio das Ostras 1
São Paulo 1
Totale 6.234
Salva come PNG Salva come JPEG
Nome #
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects 230
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 213
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 211
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 198
Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis 192
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 183
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 182
Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma 180
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 171
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 171
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors 170
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 164
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 164
SDF1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase, Pyk2. 164
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 162
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 153
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 153
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 152
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 150
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 150
Chemokine stromal cell-derived factor 1α induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals 146
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 146
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 144
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 144
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 144
17{beta}-ESTRADIOL PROMOTES BREAST CANCER CELL PROLIFERATION INDUCING SDF-1-MEDIATED EGFR TRANSACTIVATION: REVERSAL BY GEFITINIB PRE-TREATMENT. 142
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 141
Differential role of EGF and bFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensitivity 140
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 140
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 137
Mutual influence of ROS, pH and CLIC1 membrane protein in the regulation of G1/S phase progression in human glioblastoma stem cells 137
CXC receptors and chemokines expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation 135
An intracellular multi-effector complex mediates somatostatin receptor 1 regulation of phospho-tyrosine phosphatase eta activity 126
The Eighth Fibronectin Type III Domain of Protein Tyrosine Phosphatase Receptor J Influences the Formation of Protein Complexes and Cell Localization. 124
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation 118
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 117
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 114
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 114
The activation of the phosphotyrosine phosphatase h (r-PTPh) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 94
Somatostatin receptors 1, 2 and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro, via a PTPh-dependent inhibition of ERK1/2. 93
Somatostatin receptor subtype-dependent regulation of NO release: involvement of different intracellular pathways 67
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro 60
Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells 55
The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 53
A floating endometrial organoid model recapitulates epithelial-stromal cell interactions in vitro 22
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function 22
Totale 6.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.982
article - articoli 19.982
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 24 50 17 19 23 26 67 32 28
2021/2022578 27 55 28 62 20 39 35 135 32 41 22 82
2022/2023529 42 44 8 74 53 100 0 43 72 4 73 16
2023/2024355 16 29 6 43 21 90 35 17 17 12 15 54
2024/20251.202 52 62 29 109 146 124 102 279 48 42 93 116
2025/2026690 250 52 231 157 0 0 0 0 0 0 0 0
Totale 6.388